C
Chemomab Therapeutics Ltd D
D
CMMB
1.72000
USD
0.00
(0.00%)
مغلق
حجم التداول
398
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
24,697,807
المقالات
العنوان: Chemomab Therapeutics Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.